跳至主要内容
临床试验/CTRI/2025/06/088348
CTRI/2025/06/088348尚未招募2 期

EVALUATING EFFICACY OF PLATELET RICH PLASMA, INJECTABLE PLATELET RICH FIBRIN AND GROWTH FACTOR CONCENTRATE ON PROMOTING HAIR REGROWTH: A CLINICAL TRIAL

Institute of Dental Sciences , Bareilly1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2025年6月15日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
21
试验地点
1
主要终点
GFC is better than other blood components in Hair Regrowth

研究概览

简要总结

Androgenic alopecia (AGA) is the most common form of hair loss, influenced by genetics and androgens like DHT. It presents as patterned hair loss in men and diffuse thinning in women, known as Female Pattern Hair Loss (FPHL). Conventional treatments include oral finasteride and topical minoxidil but may cause side effects and inconsistent results. Hair transplants offer a solution but are expensive and may require multiple sessions. Autologous platelet concentrates are gaining attention for their regenerative properties. PRP (Platelet-Rich Plasma) is rich in growth factors that stimulate hair follicle activity and scalp regeneration. iPRF (Injectable Platelet-Rich Fibrin) offers a more bioactive and sustained release of growth factors compared to PRP. GFC (Growth Factor Concentrate) uses activated platelets to enhance vascularization and follicular repair. These therapies aim to improve hair growth, density, and follicular health in AGA patients. A comparative study is needed to determine which therapy is most effective, safe, and yields faster results.

4o

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • 1.Individuals with androgenic alopecia.
  • 2.Healthy adult individuals between18-45 years without any underlying medical conditions that may affect hair regrowth.
  • 3.Patient with androgenic alopecia of vertex grade 1-5 of Hamilton Norwood12 or grade 1-2 of Ludwig scale13 without frontal baldness.
  • 4.Person who has not taken any medical treatment for androgenic alopecia in any form in last 6 months .
  • 5.Willing to give informed consent.

排除标准

  • 1.Individuals undergoing concurrent hair loss treatments.
  • 2.Pregnant or lactating women.
  • 3.Patient with any systemic disease or long-term medication.
  • 4.Patients with any local pathology of hair inducing hair fall or undergoing treatment for the same .
  • 5.History of hair transplant .

结局指标

主要结局

GFC is better than other blood components in Hair Regrowth

时间窗: 1st, 3rd and 4th months

次要结局

  • GFC is better than other blood components in Hair Regrowth(1st, 3rd and 4th months)

研究者

发起方
Institute of Dental Sciences , Bareilly
申办方类型
Other [Private Dental College]

研究点 (1)

Loading locations...

相似试验